Organisationsprofil
 

NOXXON Pharma AG

NOXXON Pharma AG is an independent biopharmaceutical company focusing on the development of innovative pharmaceutical products based on its unique proprietary Spiegelmer® Technology. 

NOXXON's goal is the in-house development of our own Spiegelmer products through Phase II clinical trials. Complementing its own programs, NOXXON works on multiple drug discovery projects. The pursuit of licensing partnerships and collaborative Research & Development efforts is an integral part of our business strategy and plays an important role in the company's growth and success. This strategy reflects our strengths in drug discovery and  the vast potential of our unique technology platform.

 
Details
 
Adresse:
NOXXON Pharma AG

Max-Dohrn-Str. 8-10
10589 Berlin
Berlin
Deutschland
Webseite:
Arbeitsgebiet:
Klinische Forschung
Pharmaindustrie
Wissenschaftl. Forschung
Expansion:
international
Mitarbeiteranzahl:
51-500
 
Stellen
 
Diese Anzeige zu den Favoriten hinzufügen? Diese Anzeige von den Favoriten entfernen?
 
Alle
 

Über jobvector | Impressum | Privacy Policy | AGB | ©2012 jobvector | Rendered in 0,599s

 
Country|Language
Bitte wählen Sie Land und Sprache
English - Germany German - Germany
Andere Länder/Other Countries
English - Poland Polish - Poland
English - Switzerland German - Switzerland